Adline Chem Lab

Kamron_Labs.03 May 2024

Pharmaceuticals

₹

-1.23 (-5.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Adline Chem Lab

Adline Chem Lab

Pharmaceuticals

Kamron_Labs.03 May 2024

₹

-1.23 (-5.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-Mar-2024	BC	The Board of Directors of the Company at its meeting held today i.e. March 05th, 2024 (started at 02:30 P.M. and concluded at 03:00 P.M.) inter-alia considered and approved the following: Upon the re	05-Mar-2024
05-Mar-2024	BC	The Board of Directors of the Company at its meeting held today i.e. March 05th, 2024 (started at 02:30 P.M. and concluded at 03:00 P.M.) inter-alia considered and approved the following: Upon the re	05-Mar-2024
28-Feb-2024	BC	Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Mr. Kamlesh Lashkari has tendered his resignation wef February 28, 2024 (closing of business hours) ADLINE CHEM LAB LIMITED has informed	28-Feb-2024
03-Feb-2024	BC	Relating to noting of Acquisition of shares pursuant to open offer, change in Directors and KMPs and change in constitution of committees and change in Registered office address and email address of	03-Feb-2024
03-Feb-2024	BC	Appointment of Mrs. Ritu Singh qualified Company Secretary as Company secretary and Compliance officer of the Company. Pursuant to successful takeover activities and transition in management- Resi	03-Feb-2024

No Rights has been declared by Kamron_Labs.

Book Closure

Record Date	Split Date	Purpose
05-Mar-2024	-	The Board of Directors of the Company at its meeting held today i.e. March 05th, 2024 (started at 02:30 P.M. and concluded at 03:00 P.M.) inter-alia considered and approved the following: Upon the re
05-Mar-2024	-	The Board of Directors of the Company at its meeting held today i.e. March 05th, 2024 (started at 02:30 P.M. and concluded at 03:00 P.M.) inter-alia considered and approved the following: Upon the re
28-Feb-2024	-	Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Mr. Kamlesh Lashkari has tendered his resignation wef February 28, 2024 (closing of business hours) ADLINE CHEM LAB LIMITED has informed
03-Feb-2024	-	Relating to noting of Acquisition of shares pursuant to open offer, change in Directors and KMPs and change in constitution of committees and change in Registered office address and email address of
03-Feb-2024	-	Appointment of Mrs. Ritu Singh qualified Company Secretary as Company secretary and Compliance officer of the Company. Pursuant to successful takeover activities and transition in management- Resi

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Adline Chem Lab Ltd ₹23.39(-1.23/-5.00%)	23.39	-1.23	14.40	355.93	0.00	-8.57
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,334.63	67.79	83.60	20.36
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,352.61	67.42	19.82	1.38
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	114,613.75	54.95	34.85	4.43
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,274.11	29.81	51.68	8.68
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	56,534.24	18.89	49.35	18.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.07	0.39	0.53
Total Income	0.00	0.00	0.00	0.07	0.39	0.53
Total Expenditure	0.00	0.03	0.08	0.09	0.41	4.63
PBIDT	0.00	-0.03	-0.08	-0.01	-0.02	-4.10
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.00	-0.03	-0.08	-0.01	-0.02	-4.10
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.00	-0.03	-0.08	-0.01	-0.02	-4.10
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	-4.35
Adjusted Profit After Extra-ordinary item	0.00	-0.03	-0.08	-0.01	-0.02	0.25

EPS (Unit Curr.)	0.01	-0.05	-0.14	-0.02	-0.04	-7.01
EPS (Adj) (Unit Curr.)	0.01	-0.05	-0.14	-0.02	-0.04	-7.01
Calculated EPS (Unit Curr.)	0.01	-0.05	-0.14	-0.02	-0.04	-7.01
Calculated EPS (Adj) (Unit Curr.)	0.01	-0.05	-0.14	-0.02	-0.04	-7.01
Calculated EPS (Ann.) (Unit Curr.)	0.02	-0.22	-0.56	-0.09	-0.15	-28.03
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.02	-0.22	-0.56	-0.09	-0.15	-28.03
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	5.85	5.85	5.85	5.85	5.85	5.85
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PBDTM(%)	0.00	0.00	0.00	0.00	0.00	0.00
PATM(%)	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	5.85	5.85	5.85	5.85	5.85	5.85
Reserves Total	-7.42	-3.20	-3.92	-2.64	1.18	1.18
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-1.57	2.65	1.93	3.21	7.03	7.03
Secured Loans	0.00	0.00	0.00	0.00	0.00	3.77
Unsecured Loans	1.33	1.32	2.50	2.85	5.35	7.55
Total Debt	1.33	1.32	2.50	2.85	5.35	11.32
Total Liabilities	-0.24	3.97	4.43	6.06	12.38	18.35
APPLICATION OF FUNDS :
Gross Block	0.00	5.63	5.63	6.29	19.46	19.18
Less : Accumulated Depreciation	0.00	1.20	1.99	1.51	7.48	6.73
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	4.43	3.64	4.78	11.98	12.45
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.26	0.39	1.09	3.24	2.29
Sundry Debtors	0.00	0.07	1.58	1.43	2.08	2.28
Cash and Bank	0.06	0.05	-0.16	0.05	0.17	1.68
Loans and Advances	0.00	0.06	0.17	0.19	4.34	4.59
Total Current Assets	0.06	0.43	1.98	2.77	9.82	10.85
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.00	0.46	0.54	0.91	9.16	4.72
Provisions	0.00	0.15	0.25	0.25	0.01	0.00
Total Current Liabilities	0.01	0.61	0.79	1.16	9.16	4.72
Net Current Assets	0.06	-0.18	1.19	1.61	0.66	6.13
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.05	0.05	0.05	0.05
Net Deferred Tax	0.00	0.00	-0.05	-0.05	-0.05	-0.05
Total Assets	0.06	4.25	4.78	6.34	12.60	18.53
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	1.19

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.05	-0.16	0.05	0.17	1.68
Net Cash from Operating Activities	0.01	0.21	-0.29	-11.34	-0.95
Net Cash Used In Investing Activities	0.00	0.00	0.12	11.24	-0.28
Net Cash Used In Financing Activities	0.00	-0.01	-0.03	-0.02	-0.29
Net Inc./Dec In Cash And Cash Equivalents	0.01	0.20	-0.21	-0.12	-1.51
Cash And Cash Equivalents At End Of The Year	0.06	0.05	-0.16	0.05	0.17

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

29.61%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

70.39%

**Promoter pledged shareholding 29.61%

About Adline Chem Lab Ltd

Adline Chem Lab Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 14.4 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes Mahendra P Shah, Mahendra P Shah,Kamlesh J Laskari,Ranak K Laskari,Devarshi D Patel,Ritu Singh (Adline Chem Lab Ltd) among others.

Chairman

Mahendra P Shah

Registered office

904 9th Floor,Shapath-I Complex S G Highway,Ahmedabad,Gujarat,382721

FAX :91-02764-286038

Background

Incorporation Year1988

Face Value₹10

Market Lot1

How to buy Adline Chem Lab shares on nse?

To buy Adline Chem Lab shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Adline Chem Lab share price today?

The Adline Chem Lab shares price on nse is Rs.23.39 today.

What is the market cap of Adline Chem Lab shares on BSE ?

The company has a market capitalization of Rs.14.40Cr

What is the PE & PB ratio of Adline Chem Lab shares ?

PE is 0 and PB is -8.57

What is the 52 Week High and Low of Adline Chem Lab shares?

Adline Chem Lab stock price high: Rs.28.97 Adline Chem Lab stock price low: Rs.5.4